Cargando…
SOX2 haploinsufficiency is associated with slow progressing hypothalamo-pituitary tumours
SOX2 is an early developmental transcription factor and marker of stem cells that has recently been implicated in the development of the pituitary gland. Heterozygous SOX2 mutations have been described in patients with hypopituitarism and severe ocular abnormalities. In the majority of published cas...
Autores principales: | Alatzoglou, Kyriaki S, Andoniadou, Cynthia L, Kelberman, Daniel, Buchanan, Charles R, Crolla, John, Arriazu, Maria Cristina, Roubicek, Martin, Moncet, Daniel, Martinez-Barbera, Juan P, Dattani, Mehul T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Subscription Services, Inc., A Wiley Company
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487182/ https://www.ncbi.nlm.nih.gov/pubmed/21919124 http://dx.doi.org/10.1002/humu.21606 |
Ejemplares similares
-
Recent advances in central congenital hypothyroidism
por: Schoenmakers, Nadia, et al.
Publicado: (2015) -
Delayed recovery of hypothalamo-pituitary-adrenal axis
por: Kharb, Sandeep, et al.
Publicado: (2011) -
Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans
por: Gualtieri, Angelica, et al.
Publicado: (2021) -
Paracrine Signalling From SOX2-Expressing Pituitary Embryonic Cells Is Required for Terminal Differentiation of Hormone-Producing Cells
por: Manshaei, Saba, et al.
Publicado: (2021) -
Neuromedins U and S involvement in the regulation of the hypothalamo–pituitary–adrenal axis
por: Malendowicz, Ludwik K., et al.
Publicado: (2012)